Clinical question:Peritonectomy with HIPEC
ثبت نشده
چکیده
1 Background ................................................................................................................................................................ 1 2 Systematic review evidence ...................................................................................................................................... 2 2.1 Perioperative mortality, morbidity and adverse events .................................................................................... 3 2.2 Survival outcomes ............................................................................................................................................ 4 2.3 Quality-of-life outcomes ................................................................................................................................... 4 3 Evidence summary and recommendations ................................................................................................................ 4 3.1 Considerations in making these recommendations .......................................................................................... 6 3.2 Health system implications ............................................................................................................................... 6 3.2.1 Clinical practice ....................................................................................................................................... 6 3.2.2 Resourcing .............................................................................................................................................. 6 3.2.3 Barriers to implementation ..................................................................................................................... 7 4 Discussion .................................................................................................................................................................. 7 4.1 Unresolved issues ............................................................................................................................................. 7 4.2 Studies currently underway .............................................................................................................................. 7 4.3 Future research priorities ................................................................................................................................. 8 5 References ................................................................................................................................................................. 8 6 Appendices ................................................................................................................................................................ 9
منابع مشابه
Introducing Hyperthermic Intraperitoneal Chemotherapy into Gynecological Oncology Practice - Feasibility and Safety Considerations: Single-Center Experience.
BACKGROUND Within the surgical oncology community interest is increasingly focusing on combining surgical cytoreduction and regional chemotherapeutic drug delivery to manage solid abdominal tumors. In particular, the role of hyperthermic intraperitoneal chemotherapy (HIPEC) is evolving for treating epithelial ovarian carcinomas (EOCs), as EOCs remain confined to the peritoneal cavity for most o...
متن کاملCytoreductive Strategies in the Treatment of Carcinomatosis of Colorectal Origin: Results of a Transdisciplinary National Survey
Background: Many patients are not referred to centers specializing in the treatment of peritoneal malignancies. This survey evaluates Canadian physician attitudes toward the role of cytoreduction in treating colorectal carcinomatosis. Methods: A discrete-choice questionnaire containing a hypothetical scenario surveyed physician preferences for the management of colorectal carcinomatosis. Result...
متن کاملClinical history of patients with peritoneal carcinomatosis exluded from cytoreductive surgery & HIPEC.
PURPOSE The aim of this study was to explore the natural course of peritoneal carcinomatosis (PC) in patients who are not fit to undergo cytoreductive (CRS) surgery and hyperthermic intraperitoneal chemotherapy (HIPEC). METHODS Over an 8-year period (2006-2013) 320 patients were excluded from CRS and HIPEC at our center. Exclusion criteria were: (a) age >75 years; (b) ASA score ≥ 3; (c) extra...
متن کاملPressurized intraperitoneal aerosol chemotherapy (PIPAC) as a neoadjuvant therapy before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
BACKGROUND Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel drug delivery system able to induce regression of peritoneal metastasis (PM) in the salvage situation. The aim of this study was to determine the clinical characteristics, tumor histology, and extent of disease of the patients having undergone cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy ...
متن کاملDoes hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients
BACKGROUND For recurrent disease or primary therapy of advanced ovarian cancer, cytoreductive surgery (CRS) followed by adjuvant chemotherapy is a therapeutic option. The aim of this study was to evaluate the outcome for patients with epithelial ovarian cancer treated with hyperthermic intraoperative chemotherapy (HIPEC) and completeness of cytoreduction (CC). METHODS Data were retrospectivel...
متن کامل